The Advanced Therapeutics Program is a state-of-the-art translational research program aimed at developing better treatment for patients with cancer by exploring the use of immunotherapeutic approaches. Dr. Berinstein obtained his Medical Doctoral Degree at the University of Manitoba. He subsequently studied at the University of Toronto in Internal Medicine and Medical Oncology and spent four years as a post-doctoral fellow in Dr. Ron Levy's Lab at Stanford University in the area of Immunotherapy for cancer. Back in Toronto, Dr. Berinstein became a Clinician Scientist with Cancer Care Ontario. He still is actively involved in translational research at Toronto-Sunnybrook Regional Cancer Centre where he was the founding director of the Advanced Therapeutics Program.